Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects

Abstract Despite being a new promising tool for cancer therapy, intravenous delivery of oncolytic viruses (OVs) is greatly limited by poor tumor targeting, rapid clearance in the blood, severe organ toxicity, and cytokine release syndrome. Herein, a simple and efficient strategy of erythrocyte‐lever...

Full description

Bibliographic Details

Published in:	Advanced Science
Main Authors:	Mingyang Liu, Ruizhe Zhang, Hanwei Huang, Pengfei Liu, Xu Zhao, Hu Wu, Ying He, Ruizhe Xu, Xifeng Qin, Zhenguo Cheng, Hongyu Liu, Onder Ergonul, Füsun Can, Defang Ouyang, Zhenning Wang, Zhiqing Pang, Funan Liu
Format:	Article
Language:	English
Published:	Wiley 2024-02-01
Subjects:	biocompatibility erythrocytes hitchhiking oncolytic virus targeted delivery
Online Access:	https://doi.org/10.1002/advs.202303907